Cargando…
Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl(4))-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways
BACKGROUND: Hepatic stellate cell (HSC) activation is activated mainly by endotoxin and transforming growth factor (TGF-β1) in chronic liver injury, consequently, can be important therapeutic targets. Xia-yu-xue decoction (XYXD), a classical recipe used in China to treat liver fibrosis, and has been...
Autores principales: | Liu, Cheng, Yuan, Xia, Tao, Le, Cheng, Zhuoan, Dai, Xiuqin, Sheng, Xia, Xue, Dongying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486088/ https://www.ncbi.nlm.nih.gov/pubmed/26122378 http://dx.doi.org/10.1186/s12906-015-0733-1 |
Ejemplares similares
-
Retraction Note: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways
por: Liu, Cheng, et al.
Publicado: (2022) -
Uncovering the potential mechanism of Xue Fu Zhu Yu Decoction in the treatment of intracerebral hemorrhage
por: Xue, Dao-jin, et al.
Publicado: (2022) -
Efficacy and Safety of Xue-Fu-Zhu-Yu Decoction for Patients with Coronary Heart Disease: A Systematic Review and Meta-Analysis
por: Zhang, Shuo, et al.
Publicado: (2021) -
The Improvement of Cardiac and Endothelial Functions of Xue-Fu-Zhu-Yu Decoction for Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Chen, Shiqi, et al.
Publicado: (2022) -
Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode
por: Zhang, Guohua, et al.
Publicado: (2016)